ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $728 | -59.6% | 40,539 | -54.2% | 0.01% | -53.3% |
| Q2 2023 | $1,802 | -38.2% | 88,585 | -33.9% | 0.02% | -37.5% |
| Q1 2023 | $2,917 | -1.2% | 134,042 | +40.7% | 0.02% | -44.2% |
| Q4 2022 | $2,952 | -99.7% | 95,258 | +162.8% | 0.04% | +258.3% |
| Q3 2022 | $925,000 | -57.7% | 36,241 | -66.3% | 0.01% | -55.6% |
| Q2 2022 | $2,185,000 | +14.0% | 107,624 | +39.0% | 0.03% | +12.5% |
| Q1 2022 | $1,916,000 | +830.1% | 77,446 | +919.2% | 0.02% | +700.0% |
| Q3 2021 | $206,000 | -76.4% | 7,599 | -77.4% | 0.00% | -70.0% |
| Q2 2021 | $873,000 | +323.8% | 33,679 | +141.4% | 0.01% | +150.0% |
| Q3 2020 | $206,000 | -68.1% | 13,949 | -51.7% | 0.00% | -76.5% |
| Q2 2020 | $646,000 | – | 28,900 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |